The Cannabis Company That Won't Mix Work With Pleasure
A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully.
For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users.
“If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said.
Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market.
“It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.”
And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021.
For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).
Michael Boyd, CEO of aviation consultancy Boyd Group International, joined Cheddar to discuss recent mass flight cancellations by airlines like American and Southwest. Boyd noted that the usually efficient hub and spoke system left American Airlines vulnerable to the weather event in Dallas-Fort Worth and staffing shortages. He also said that while planning trips in the current climate can be unnerving, problems like weather delays are just part of the flying experience.
Christian Kroll, CEO of Ecosia, joins 'Fast Forward' to discuss how Ecosia uses its ad revenue to plant trees, and what the company plans to do after launching a $405 million venture capital fund focused on combating the climate crisis.
Guy Hirsch, USA managing director and head of NFT at eToro, joined Cheddar to discuss the evolution of bitcoin into the mainstream 13 years after the white paper from the presumed pseudonym Satoshi Nakamoto was published. Hirsch said there were several groundbreaking moments for the cryptocurrency, starting with the financial crisis of 2008, noting that people began seeking a solution to protect wealth, and bitcoin "gave people the confidence that it is an immutable ledger that no one can really hack or interfere with."
Visa CFO Vasant Prabhu, joined Cheddar's "Closing Bell" to talk about the financial service company's prediction that a full economic recovery from the pandemic won't happen until summer 2023 based on travel-related sources. Prabhu noted that a big question mark for the recovery is when Asia reopens for travel but "anything's possible" and the recovery could still end up going faster than anticipated.
Clinical research company Medable has secured $304 million in Series D funding, marking its fourth round since 2020, giving the firm a valuation of just over $2 billion. Dr. Michelle Longmire, CEO and Co-founder, Medable joined Cheddar's Opening Bell to discuss the future of the company.
House Democrats are scrambling to hold a vote as soon as Tuesday on President Joe Biden's economic agenda — both the $1 trillion bipartisan infrastructure bill and the $1.85 trillion social safety net and climate bill. With Biden still overseas, the bill stands in flux. Jennifer Haberkorn, congressional reporter at the Los Angeles Times, joined Cheddar's "Opening Bell" to discuss.
Sportradar, a global sports data company, announced it will serve as UEFA’s exclusive authorized collector and distributor of data for betting purposes. The agreement covers 1,550 matches from the 2021-2022 season through to the end of the 2023-2024 season across all UEFA properties in Europe. Sportradar CEO Carsten Koerl joined Cheddar to provide additional details on the landmark partnership and some insight into the future of sports betting.
